T1850000
Tretinoin
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 302-79-4
Synonym(S): Retinoic acid, ATRA, Tretinoin, Vitamin A acid, all-trans-Retinoic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 50 MG | T1850000-50-MG | In Stock | ₹ 16,107.60 |
T1850000 - 50 MG
In Stock
Quantity
1
Base Price: ₹ 16,107.60
GST (18%): ₹ 2,899.368
Total Price: ₹ 19,006.968
biological source
synthetic
grade
pharmaceutical primary standard
Agency
EP
API family
tretinoin
form
solid
manufacturer/tradename
EDQM
technique(s)
gas chromatography (GC): suitableliquid chromatography (LC): suitable
mp
180-181 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Medchemexpress LLC HY-14649 500mg , Retinoic acid CAS:302-79-4 Purity:>98% | -- | ₹ 7,289.10 | ||
Apexbio Technology LLC Tretinoin (Aberela), 1g Cas# 302-79-4 | -- | ₹ 8,544.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Tretinoin European Pharmacopoeia (EP) Reference Standard | 302-79-4 | MFCD00001551 | | -- | ₹ 17,007.90 | ||
eMolecules Ambeed / (2E4E6E8E)-37-Dimethyl-9-(266-trimethylcyclohex-1-en-1-yl)nona-2468-tetraenoic acid / 10g / 552555987 / A126336 / / 302-79-4 / [null] / 300.442 / C20H28O2 | -- | ₹ 4,153.63 | ||
Cayman Chemical all-trans Retinoic Acid, 302-79-4, 500 mg | -- | ₹ 7,164.50 | ||
Enzo Life Sciences Retinoic acid, all trans (500 mg) CAS: 302-79-4 | -- | ₹ 8,392.70 | ||
Medchemexpress LLC HY-14649 1g Medchemexpress, Retinoic acid CAS:302-79-4 Purity:>98% | -- | ₹ 8,971.20 | ||
Cayman Chemical all-trans Retinoic Acid, 302-79-4, 50 mg | -- | ₹ 4,165.20 | ||
Tretinoin | -- | ₹ 14,765.30 | ||
Retinoic acid | -- | ₹ 4,275.88 - ₹ 1,02,296.25 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the authority of the issuing pharmacopoeia. For further information and support please go to the website of the issuing pharmacopoeia. Tretinoin is a medication used to treat a variety of skin conditions such as photodamaged skin, acne, etc. It is used as an anti-aging product and also as an oral treatment for leukemia.[1]
- Application: This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: all−trans−Retinoic acid (ATRA) is a ligand for both the retinoic acid receptor (RAR) and the retinoid X receptor (RXR). The bound RAR and RXR act as transcription factors that regulate the growth and differentiation of both normal and malignant cells. Cytochromes P450 (CYPs) catalyze the 4-hydroxylation of ATRA. Retinoic acid primes embryonic stem cells to become neurons.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P202 - P264 - P273 - P301 + P312 - P302 + P352 - P308 + P313
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 1B - Skin Irrit. 2
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable